Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Uterine Disorders Clinical Trials

A listing of Uterine Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (56) clinical trials

The primary objective of this study is to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo. The secondary objectives of this study are to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Phase

To evaluate the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy in the management of endometriosis-associated pain (EAP) in premenopausal women.

Phase

Endometriosis is a common chronic condition that can cause pain in the lower part of the stomach (pelvis) during menstrual period and at other times and pain during sexual intercourse. Northern California Research is conduction a study for premenopausal women with endometriosis. Northern California Research is conducting a study that ...

Phase

This is phase 3b study seeks to evaluate the safety and efficacy of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. This study is double-blinded in the first year and an open-label in the second year.

Phase

The purpose of this study is to determine the benefit and safety of relugolix 40 mg once daily co-administered with low dose estradiol and norethindrone acetate compared with placebo for 24 weeks on heavy menstrual bleeding associated with uterine fibroids. Additionally, this study is designed to evaluate the benefit of ...

Phase

The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects including the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy.

Phase

The purpose of this study is to determine the benefit and safety of relugolix 40 mg once daily, co-administered with low-dose estradiol and norethindrone acetate compared with placebo for 24 weeks, on dysmenorrhea and on nonmenstrual pelvic pain.

Phase

A phase 3 study that evaluates the safety and effectiveness of Elagolix in combination with the naturally produced hormone Estradiol for subjects with moderate to severe Endometriosis associated pain.

Phase

This study is looking at the safety and effectiveness of a new investigational medication to treat endometriosis and associated pain. The study is comparing the investigational medication to placebo and a low-dose hormone.

Phase